This inventor holds 2 USPTO granted patents, plus 2 CIPO patents and 4 EPO patents. Top assignees: Istituto Europeo Di Oncologia S.r.l., Nerviano Medical Sciences S.r.l.. Active years: 2013-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Genoa, IT (2013)
- Como, IT (2020)
Company Filing History:

Years Active: 2013-2020
Title: Paolo Trifiro': Innovator in Protein Kinase Inhibitors
Introduction
Paolo Trifiro' is a notable inventor based in Genoa, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the development of protein kinase inhibitors. His work is crucial in addressing diseases associated with disregulated protein kinase activity, such as cancer.
Latest Patents
Trifiro' holds a patent for 3,4-diarylpyrazoles as protein kinase inhibitors. This patent includes 3,4-diarylpyrazole derivatives of a specific formula, along with pharmaceutically acceptable salts. The patent outlines the process for their preparation and the pharmaceutical compositions that comprise these compounds. The compounds developed may be beneficial in therapeutic applications for treating various diseases linked to protein kinase activity.
Career Highlights
Paolo Trifiro' is associated with Nerviano Medical Sciences S.r.l., where he continues to advance his research and development efforts. His work has positioned him as a key figure in the pharmaceutical industry, particularly in the area of cancer treatment.
Collaborations
Trifiro' has collaborated with notable colleagues, including Maurizio Pulici and Fabio Zuccotto. These partnerships have enhanced the research and development processes within their projects.
Conclusion
Paolo Trifiro' exemplifies innovation in the pharmaceutical sector through his work on protein kinase inhibitors. His contributions are vital for the advancement of therapies aimed at treating serious diseases like cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile